PB
SIOX

Pinnacle Bancorp’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Pinnacle Bancorp’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$4K Buy
+38
New +$3.98K ﹤0.01% 583

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return

Pinnacle Bancorp's SIOX Position: Q1 2017 in Review

Pinnacle Bancorp opened a new position in Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2017: 38 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #583 among its holdings.

97 funds tracked by Wall St. Rank hold SIOX as of Q1 2017.

  • Pinnacle Bancorp held 38 shares of Sio Gene Therapies Inc. Common Stock worth $4K as of Q1 2017.
  • Sio Gene Therapies Inc. Common Stock was a new Pinnacle Bancorp position in Q1 2017.
  • Sio Gene Therapies Inc. Common Stock made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q1 2017, its #583 holding.
  • 97 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2017.

Based on Pinnacle Bancorp's 13F filing for Q1 2017, filed 17 Apr 2017.